- Home
- WKHS vs CRIS Comparison
WKHS vs CRIS Comparison
Compare WKHS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | CRIS |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 14.0M |
| IPO Year | 2008 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WKHS | CRIS |
|---|---|---|
| Price | $3.23 | $0.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $16.50 |
| AVG Volume (30 Days) | 58.6K | ★ 117.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | N/A | ★ N/A |
| Revenue | $763,173.00 | ★ $9,898,000.00 |
| Revenue This Year | $81.01 | $6.13 |
| Revenue Next Year | $34.00 | $7.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.53 | $0.77 |
| 52 Week High | $11.80 | $3.18 |
Technical Indicators
Market Signals| Indicator | WKHS | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 31.65 | 41.08 |
| Support Level | $3.22 | $0.95 |
| Resistance Level | $6.00 | $1.04 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 10.00 | 12.75 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.